Pages that link to "Q35557495"

The following pages link to Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies (Q35557495):

Displaying 26 items.

• Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain. (Q30364309) (← links)
• Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a. (Q35557994) (← links)
• Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection (Q35787699) (← links)
• Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant (Q35861270) (← links)
• Immunoglobulin with High-Titer In Vitro Cross-Neutralizing Hepatitis C Virus Antibodies Passively Protects Chimpanzees from Homologous, but Not Heterologous, Challenge (Q35913863) (← links)
• Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A. (Q36288404) (← links)
• HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice. (Q37471718) (← links)
• Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targets (Q37698939) (← links)
• The past, present and future of neutralizing antibodies for hepatitis C virus (Q38192357) (← links)
• Identification of a novel epitope in the C terminus of hepatitis C virus-E2 protein that induces potent and cross-reactive neutralizing antibodies. (Q38715557) (← links)
• A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance. (Q38809451) (← links)
• Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors (Q39115641) (← links)
• Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay. (Q40098163) (← links)
• Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors (Q40271353) (← links)
• Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity. (Q40634075) (← links)
• Neutralizing antibodies in patients with chronic hepatitis C and correlation to liver cirrhosis and estimated duration of infection (Q40736190) (← links)
• Innate and Adaptive Immune Responses in Chronic HCV Infection (Q41035955) (← links)
• Viral hepatitis: Cell-culture-derived HCV--a promising vaccine antigen (Q45783350) (← links)
• Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry. (Q52371420) (← links)
• Epidemic history of hepatitis C virus genotypes and subtypes in Portugal (Q56395674) (← links)
• Defining Breadth of Hepatitis C Virus Neutralization (Q56395915) (← links)
• Hepatitis C virus escape studies for human antibody AR3A reveals a high barrier to resistance and novel insights on viral antibody evasion mechanisms (Q59349677) (← links)
• Hepatitis C virus escape studies for human monoclonal antibody AR4A reveal isolate-specific resistance and a high barrier to resistance (Q59354660) (← links)
• Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors (Q59357948) (← links)
• Antibody Repertoire Analysis of Hepatitis C Virus Infections Identifies Immune Signatures Associated With Spontaneous Clearance (Q60938455) (← links)
• Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design (Q92113260) (← links)